Standout Papers
Immediate Impact
7 from Science/Nature 75 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
Works of Thomas M. Jahn being referenced
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
2014 Standout
A Phase 1 Study Of The Selective PI3Kδ Inhibitor Idelalisib (GS-1101) In Combination With Therapeutic Anti-CD20 Antibodies (Rituximab or Ofatumumab) In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas M. Jahn | 625 | 428 | 211 | 237 | 22 | 725 | |
| Elizabeth Bilotti | 573 | 451 | 202 | 231 | 29 | 814 | |
| Kerstin Allen | 460 | 465 | 241 | 255 | 17 | 733 | |
| A. M. Liberati | 464 | 352 | 155 | 116 | 19 | 670 | |
| Sandra Kanan | 518 | 460 | 287 | 86 | 23 | 743 | |
| Silvia Martinelli | 364 | 191 | 219 | 222 | 27 | 617 | |
| Jennifer Orchard | 580 | 432 | 283 | 98 | 16 | 730 | |
| Sasanka M. Handunnetti | 535 | 482 | 148 | 107 | 23 | 712 | |
| Marwan Kwok | 513 | 417 | 272 | 310 | 15 | 850 | |
| Renee Leduc | 454 | 392 | 172 | 177 | 31 | 659 | |
| Anton Parker | 422 | 303 | 228 | 277 | 24 | 659 |
All Works
Loading papers...